Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Outcome of Dexamethasone and Methylprednisolone Treatment for Patients With ARDS Caused by COVID-19

NCT04499313 is registered in ClinicalTrials.gov with Chattogram General Hospital as lead sponsor.

NCT NCT04499313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04499313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Outcome of Dexamethasone and Methylprednisolone Treatment for Patients With ARDS Caused by COVID-19
Lead sponsor
Chattogram General Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
August 2, 2020
Completion date
November 30, 2020
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid19